Skip to main content

Spyre Therapeutics, Inc.

SYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001636282

In the last 90 days, Spyre Therapeutics, Inc. insiders filed 0 open-market purchases and 9 sales; 265 institutions reported holding it in 13F filings for Q2 2026, worth $8.52B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in Spyre Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
77
0 vs. Q2 2021
Shares held
40.6M
+2.04M (+5.3%) vs. Q2 2021
Total value
$322.5M
+$54.3M (+20.2%) vs. Q2 2021
New holders
10
24 more added
Sold out
10
23 more reduced

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 77 institutions
Q1 2021: 84 institutionsQ2 2021: 78 institutionsQ3 2021: 77 institutionsQ4 2021: 86 institutionsQ1 2022: 84 institutionsQ2 2022: 67 institutionsQ3 2022: 55 institutionsQ4 2022: 51 institutionsQ1 2023: 45 institutionsQ2 2023: 44 institutionsQ3 2023: 29 institutionsQ4 2023: 54 institutionsQ1 2024: 103 institutionsQ2 2024: 107 institutionsQ3 2024: 119 institutionsQ4 2024: 131 institutionsQ1 2025: 129 institutionsQ2 2025: 129 institutionsQ3 2025: 137 institutionsQ4 2025: 153 institutionsQ1 2026: 198 institutionsQ2 2026: 265 institutions
Value heldQ3 2021: $322.5M
Q1 2021: $328.7MQ2 2021: $285.8MQ3 2021: $322.5MQ4 2021: $189.4MQ1 2022: $95.4MQ2 2022: $24.8MQ3 2022: $23.5MQ4 2022: $19.2MQ1 2023: $12.0MQ2 2023: $31.9MQ3 2023: $43.9MQ4 2023: $601.0MQ1 2024: $1.21BQ2 2024: $1.18BQ3 2024: $1.51BQ4 2024: $1.39BQ1 2025: $1.00BQ2 2025: $952.6MQ3 2025: $1.08BQ4 2025: $2.65BQ1 2026: $4.16BQ2 2026: $8.52B
Institutions holding SYRE and their total value by quarter
QuarterHoldersValue
Q2 2026265$8.52B
Q1 2026198$4.16B
Q4 2025153$2.65B
Q3 2025137$1.08B
Q2 2025129$952.6M
Q1 2025129$1.00B
Q4 2024131$1.39B
Q3 2024119$1.51B
Q2 2024107$1.18B
Q1 2024103$1.21B
Q4 202354$601.0M
Q3 202329$43.9M
Q2 202344$31.9M
Q1 202345$12.0M
Q4 202251$19.2M
Q3 202255$23.5M
Q2 202267$24.8M
Q1 202284$95.4M
Q4 202186$189.4M
Q3 202177$322.5M
Q2 202178$285.8M
Q1 202184$328.7M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding Spyre Therapeutics, Inc.; share changes are against Q2 2021.

Institutions holding SYRE in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Berman Capital Advisors, LLC56$00.00%+56New
Daiwa Securities Group Inc.98$1.00K0.00%00.0%Unchanged
Penserra Capital Management LLC1,120$8.00K0.00%+5+0.4%Added
Quadrant Capital Group LLC1,137$9.00K0.00%00.0%Unchanged
Wells Fargo & Company2,212$18.0K0.00%00.0%Unchanged
Russell Investments Group, Ltd.3,008$23.0K0.00%−21,027−87.5%Reduced
IFP Advisors, Inc2,980$24.0K0.00%−1,000−25.1%Reduced
Legal & General Group Plc3,264$26.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,250$26.0K0.00%+229+7.6%Added
Ameritas Investment Partners, Inc.3,710$29.0K0.00%00.0%Unchanged
Royal Bank of Canada5,468$44.0K0.00%+2,502+84.4%Added
Citigroup Inc7,133$57.0K0.00%+2,150+43.1%Added
Lazard Asset Management LLC8,801$69.0K0.00%+8,801New
BNP Paribas Arbitrage, SA10,756$85.5K0.00%+6,051+128.6%Added
Personal Cfo Solutions, LLC10,888$87.0K0.02%−500−4.4%Reduced
Gsa Capital Partners LLP11,242$89.0K0.01%+11,242New
Susquehanna International Group, LLP11,192$89.0K0.00%+11,192New
Metropolitan Life Insurance Co11,616$92.3K0.00%+11,616New
HighVista Strategies LLC13,137$105.0K0.07%+13,137New
Invesco Ltd.14,726$117.0K0.00%+1,681+12.9%Added
MetLife Investment Management15,353$122.1K0.00%+15,353New
ProShare Advisors LLC15,658$124.0K0.00%−3,635−18.8%Reduced
Barclays PLC16,524$131.0K0.00%+10,856+191.5%Added
New York State Common Retirement Fund17,079$136.0K0.00%−14,405−45.8%Reduced
JPMorgan Chase & Co19,187$152.0K0.00%−68,446−78.1%Reduced
Voya Investment Management LLC19,878$158.0K0.00%00.0%Unchanged
California State Teachers Retirement System21,698$172.0K0.00%−34,163−61.2%Reduced
American International Group, Inc.22,120$176.0K0.00%−525−2.3%Reduced
Deutsche Bank AG23,243$185.0K0.00%−750−3.1%Reduced
Manufacturers Life Insurance Company, The25,323$201.0K0.00%−1,200−4.5%Reduced
Alliancebernstein L.P.25,600$204.0K0.00%00.0%Unchanged
Bank of America Corp25,639$204.0K0.00%+5,423+26.8%Added
D. E. Shaw & Co., Inc.28,503$227.0K0.00%−17,478−38.0%Reduced
SG Americas Securities, LLC28,578$227.0K0.00%+28,578New
Algert Global LLC36,804$293.0K0.04%−4,696−11.3%Reduced
Parametric Portfolio Associates LLC45,106$359.0K0.00%+11,958+36.1%Added
Blair William & Co52,204$415.0K0.00%00.0%Unchanged
Rhumbline Advisers54,143$430.0K0.00%+1,476+2.8%Added
UBS Group AG54,220$431.0K0.00%+2,143+4.1%Added
Ritholtz Wealth Management76,490$608.0K0.04%−98,156−56.2%Reduced
Charles Schwab Investment Management Inc99,477$791.0K0.00%−6,302−6.0%Reduced
Renaissance Technologies LLC100,300$797.0K0.00%+49,513+97.5%Added
Franklin Street Advisors Inc103,600$824.0K0.07%00.0%Unchanged
AlphaCentric Advisors LLC110,000$875.0K0.22%+17,500+18.9%Added
Fan Yu112,044$891.0K15.31%00.0%Unchanged
Bank of New York Mellon Corp159,488$1.27M0.00%+12,087+8.2%Added
Nuveen Asset Management, LLC179,642$1.34M0.00%−4,629−2.5%Reduced
Morgan Stanley194,225$1.54M0.00%−1,310−0.7%Reduced
Abingworth LLP240,500$1.91M0.43%00.0%Unchanged
University of Texas/Texas Am Investment Managment Co245,678$1.95M1.12%−23,900−8.9%Reduced
Assenagon Asset Management S.A.267,066$2.12M0.01%−15,002−5.3%Reduced
Lion Point Capital, LP300,000$2.38M0.63%00.0%Unchanged
Marshall Wace, LLP315,823$2.51M0.01%−335,580−51.5%Reduced
Northern Trust Corp365,703$2.91M0.00%−2,637−0.7%Reduced
AXA S.A.439,667$3.50M0.01%+15,315+3.6%Added
Sio Capital Management, LLC446,000$3.55M1.14%+43,347+10.8%Added
Millennium Management LLC535,222$4.25M0.01%−7,963−1.5%Reduced
Laurion Capital Management LP606,638$4.82M0.07%+606,638New
Altium Capital Management LP609,689$4.85M1.29%00.0%Unchanged
Dimensional Fund Advisors LP632,833$5.03M0.00%+28,721+4.8%Added
Geode Capital Management, LLC689,997$5.49M0.00%+12,271+1.8%Added
State Street Corp766,941$6.10M0.00%+9,441+1.2%Added
Samsara BioCapital, LLC883,720$7.03M1.17%00.0%Unchanged
Great Point Partners LLC900,000$7.16M1.69%00.0%Unchanged
Artal Group S.A.1,045,000$8.31M0.20%00.0%Unchanged
Goldman Sachs Group Inc1,136,050$9.03M0.00%+4,991+0.4%Added
Nantahala Capital Management, LLC1,516,955$12.1M0.71%−160,081−9.5%Reduced
Rock Springs Capital Management LP1,577,296$12.5M0.26%00.0%Unchanged
Aisling Capital Management LP1,691,151$13.4M2.68%00.0%Unchanged
Vanguard Group Inc2,108,760$16.8M0.00%+11,594+0.6%Added
Suvretta Capital Management, LLC2,157,727$17.2M0.29%+63,627+3.0%Added
Pictet Asset Management SA2,532,799$20.1M0.02%+2,532,799New
Bain Capital Life Sciences Investors, LLC2,847,689$22.6M1.40%+147,689+5.5%Added
BlackRock Inc.2,983,895$23.7M0.00%−119,984−3.9%Reduced
Baker Bros. Advisors LP3,410,106$27.1M0.12%00.0%Unchanged
Adage Capital Partners GP, L.L.C.3,500,000$27.8M0.05%+450,419+14.8%Added
OrbiMed Advisors LLC4,015,524$31.9M0.35%00.0%Unchanged
Boxer Capital, LLC0$00.00%−550,000−100.0%Sold out
Point72 Asset Management, L.P.0$00.00%−469,765−100.0%Sold out
Jacobs Levy Equity Management, Inc0$00.00%−59,294−100.0%Sold out
Ergoteles LLC0$00.00%−34,100−100.0%Sold out
California Public Employees Retirement System0$00.00%−20,841−100.0%Sold out
Cerity Partners LLC0$00.00%−18,000−100.0%Sold out
Cubist Systematic Strategies, LLC0$00.00%−11,722−100.0%Sold out
O'Shaughnessy Asset Management, LLC0$00.00%−1,654−100.0%Sold out
Group One Trading, L.P.0$00.00%−300−100.0%Sold out
Ellevest, Inc.0$00.00%−150−100.0%Sold out
Pictet Asset Management Ltd––––Not filed